Nimodipine (Capsule, Liquid Filled)

dailymed-instance:drugs, http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer

dailymed-ingredient:Nimodipine

DO NOT ADMINISTER NIMODIPINE INTRAVENOUSLY OR BY OTHER PARENTERAL ROUTES. DEATHS AND SERIOUS, LIFE-THREATENING ADVERSE EVENTS HAVE OCCURRED WHEN THE CONTENTS OF NIMODIPINE CAPSULES HAVE BEEN INJECTED PARENTERALLY (See WARNINGS and DOSAGE AND ADMINISTRATION).

dailymed-ingredient:FD&C_yellow_no._6, dailymed-ingredient:ammonium_hydroxide, dailymed-ingredient:anhydrous_glycerin, dailymed-ingredient:black_iron_oxide, dailymed-ingredient:fractionated_coconut_oil, dailymed-ingredient:gelatin, dailymed-ingredient:peppermint_oil, dailymed-ingredient:polyethylene_glycol, dailymed-ingredient:polyvinyl_acetate_phthalate, dailymed-ingredient:propylene_glycol, dailymed-ingredient:sorbitol_glycerin_blend, dailymed-ingredient:titanium_dioxide

Nimodipine (Capsule, Liquid Filled)

http://www4.wiwiss.fu-berlin.de/dailymed/resource/routeOfAdministration/Oral